« Previous
Next »
The American Journal of Surgery
Volume 193, Issue 4
, Pages 438-442
, April 2007
Two-phase scintigraphy with technetium 99m–sestamibi in patients with hyperparathyroidism due to chronic renal failure
References
- . Parathyroid imaging: preoperative localization. Nucl Med Commun. 2003;24:125–131
- Preoperative imaging of parathyroid glands with technetium99m labeled sestamibi and iodine 123 subtraction scanning in secondary hyperparathyroidism. Lancet. 1999;353:2200–2204
- Technetium 99m-sestamibi/ pertechnetate subtraction scintigraphy vs ultrasonography for preoperative localization in primary hyperparathyroidism. Eur Radiol. 2002;12:605–609
- . Optimization of preoperative procedures. Nucl Med Commun. 2003;24:133–140
- 99mTc-methoxyisobutilisonitrile imaging for parathyroid adenoma: Relationship tp P-glycoprotein or multidrug resistence-related protein espression. Eur J Nucl Med Mol Imaging. 2002;29:1012–1015
- Localization of parathyroid glands in hemodialysis patients using 99mTc sestamibi imaging. Nephrol Dial Transplant. 1998;13(suppl 3):103–104
- . Biological factors influencing parathyroid localization. Nucl Med Commun. 2003;24:121–124
- Has double-phase MIBI scintigraphy usefulness in the diagnosis of hyperparathyroidism?. Nephrol Dial Transplant. 1998;13(suppl 3):37–40
- Preoperative localization of enlarged parathyroid glands by 99mTc-MIBI scintigraphy. Nippon Hinyokika Gakkai Zasshi. 1997;88:795–800
- Magnetic resonance imaging (MRI) and technetium 99m-methoxyisonitrile (MIBI) scintigraphy to evaluate the abnormal parathyroid gland and PEIT efficacy for secondary hyperparathyroidism. Med Imag Radiat Oncol. 1999;17:275–282
- Relation between technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the paarathyroid glands. World J Surg. 2002;26:29–34
- Parathyroid detection in secondary hyperparathyroidism with 123I/99mtc-Sestamibi subtraction single photon emission computed tomography. J Clin Endocrinol Metabol. 1998;83:3867–3871
- . Parathyroid growth: normal and abnormal. In: Bilezikian JP, Marcus R, Levine MA editor. The Parathyroid. 2th ed.. San Diego, CA: Academic Press; 2001;p. 293–331
- . Pathogenesis of parathyroid dysfunction in end-stage renal disease. Adv Renal Replace Ther. 2002;3:159–167
- 99mTc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism. World J Surg. 2000;24:1386–1390
- Sestamibi scanning and minimally invasive radioguided surgery without intraoperative parathyroid hormone measurement. Ann Surg. 2003;237:722–730
- Has double-phase MIBI scintigraphy usefulness in the diagnosis of hyperparathyroidism?. Nephrol Dial Transplant. 1998;13(suppl 3):37–40
- Relation between Tc-99m sestamibi uptake and biological factors in hyperparathyroidism. Ann Nucl Med. 2005;19:387–392
- Can we use 99mTc-MIBI in functional studies of the parathyroid gland?. Nephrol Dial Transplant. 1998;13(suppl 3):33–36
- 99mTc-sestamibi scintigraphy in chronic haemodialysis patients: static and dynamic explorations. Nephrol Dial Transplant. 2000;15:1201–1206
- Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography. Nucl Med Commun. 2003;24:755–762
- Clinical value of parathyroid scintigraphy with 99mTc-methoxyisobutilisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature. Worl J Surg. 2004;28:100–107
- The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism. J Nucl Med. 2004;45:40–48
- Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression. Surgery. 2002;132:968–974
PII: S0002-9610(07)00015-3
doi: 10.1016/j.amjsurg.2006.08.078
© 2007 Excerpta Medica Inc. All rights reserved.
« Previous
Next »
The American Journal of Surgery
Volume 193, Issue 4
, Pages 438-442
, April 2007
